Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of pneumonia and ARDS with inhibitors of C5a and IL-6 activity

Treatment of pneumonia and ARDS with inhibitors of C5a and IL-6 activity

US Patent 12180274 · Granted Dec 31, 2024

Estimated economic value: $2,534,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused piperidinyl bicyclic and related compounds as modulators of C5a receptor2024
Fused piperidinyl bicyclic and related compounds as modulators of C5a receptor2024
Treatment of inflammatory diseases with inhibitors of C5A activity2024
Treatment of inflammatory diseases with inhibitors of C5A activity2024
Treatment of inflammatory diseases with inhibitors of C5A activity2022
Treatment of inflammatory diseases with inhibitors of C5A activity2022
Treatment of inflammatory diseases with inhibitors of C5a activity2022
Fused piperidinyl bicyclic and related compounds as modulators of C5A receptor2021
Fused piperidinyl bicyclic and related compounds as modulators of C5A receptor2021
Inhibitors of C5A for the treatment of viral pneumonia2020
Inhibitors of C5A for the treatment of viral pneumonia2020
Anti-C5a binding moieties with high blocking activity2020